Last reviewed · How we verify
NCT03222752
Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder
NA trial testing Cranial Electrotherapy Stimulation in Major Depressive Disorder in 5 participants. Terminated before completion.
25 April 2023
Quick facts
| Lead sponsor | Electromedical Products International, Inc. |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 5 June 2017 |
| Primary completion | 25 April 2023 |
| Estimated completion | 25 April 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cranial Electrotherapy Stimulation
- Sham Cranial Electrotherapy Stimulation
Conditions studied
- Major Depressive Disorder — all drugs for Major Depressive Disorder →
Sponsor
Electromedical Products International, Inc. — full company profile →
Who can join
Adults 22 to 65, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Efficacy of Cranial Electrotherapy Stimulation (CES) for the treatment of Major Depressive Disorder
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03222752
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cranial Electrotherapy Stimulation
Trials testing the same drug.
- NCT04961112 — Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits · NA · completed
- NCT04587531 — Neural Mechanisms With CES in Depression · NA · terminated
Other recruiting trials for Major Depressive Disorder
Currently open trials in the same condition.
- NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
- NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
- NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting
Other Electromedical Products International, Inc. trials
Trials by the same sponsor.
- NCT06124014 — CES for the Treatment of GAD in Young Adults · NA · completed
- NCT05772702 — Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression · NA · completed
- NCT04587531 — Neural Mechanisms With CES in Depression · NA · terminated
- NCT04963907 — Alpha-Stim AID and Major Depressive Disorder · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03222752 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Electromedical Products International, Inc.
- Last refreshed: 27 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03222752.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing